|
[1]LI YM, CHEN WX, YU CH, et al.An epidemiological survey of alcoholic liver disease in Zhejiang province[J].Chin J Hepatol, 2003, 11 (11) :647-649. (in Chinese) 厉有名, 陈卫星, 虞朝辉, 等.浙江省酒精性肝病流行病学调查概况[J].中华肝脏病杂志, 2003, 11 (11) :647-649.
|
|
[2]PENG L, GAN HT, OUYANG Q.A multicenter study of alcoholic liver disease in China[J].Chin J Dig, 2007, 27 (4) :231-234. (in Chinese) 彭兰, 甘华田, 欧阳钦.丝裂原活化蛋白激酶选择性抑制剂对葡聚糖硫酸钠结肠炎的影响[J].中华消化杂志, 2007, 27 (4) :231-234.
|
|
[3]CHEN SL, MENG XD, WANG BY, et al.An epidemiologic survey of alcoholic liver disease in some cities of Liaoning Province[J].J Clin Hepatol, 2010, 13 (6) :428-430. (in Chinese) 陈士林, 孟晓丹, 王炳元, 等.辽宁省部分城市酒精性肝病流行现状调查[J].实用肝脏病杂志, 2010, 13 (6) :428-430.
|
|
[4]GAO B, BATALLER R.Alcoholic liver disease:novel concepts and therapeutic targets[J].Gastroenterology, 2011, 141 (5) :1572-1585.
|
|
[5]WAGNER M, ZOLLNER G, TRAUNER M.Nuclear receptors in liver disease[J].Hepatology, 2011, 53 (3) :1023-1034.
|
|
[6]CZAJA MJ.Functions of autophagy in hepatic and pancreatic physiology and disease[J].Gastroenterology, 2011, 140 (7) :1895-1908.
|
|
[7]DING WX, LI M, CHEN X, et al.Autophagy reduces acute ethanolinduced hepatotoxicity and steatosis in mice[J].Gastroenterology, 2010, 139 (5) :1740-1752.
|
|
[8]KENDRICK SF, O’BOYLE G, MANN J, et al.Acetate, the key modulator of inflammatory responses in acute alcoholic hepatitis[J].Hepatology, 2010, 51 (6) :1988-1997.
|
|
[9]TATSUKAWA H, FUKAYA Y, FRAMPTON G, et al.Role of transglutaminase 2 in liver injury via cross-linking and silencing of transcription factor Sp1[J].Gastroenterology, 2009, 136 (5) :1783-1795, e10.
|
|
[10]PRITCHARD MT, McMULLEN MR, STAVITSKY AB, et al.Differential contributions of C3, C5, and decay-accelerating factor to ethanolinduced fatty liver in mice[J].Gastroenterology, 2007, 132 (3) :1117-1126.
|
|
[11] MILLER AM, WANG H, BERTOLA A, et al.Inflammation-associated IL-6/STAT3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in IL-10 deficient mice[J].Hepatology, 2011, 54 (3) :846-856.
|
|
[12]DOMINGUEZ M, MIQUEL R, COLMENERO J, et al.Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis[J].Gastroenterology, 2009, 136 (5) :1639-1650.
|
|
[13] BERTOLA A, MATHEWS S, KI SH, et al.Mouse model of chronic and binge ethanol feeding (the NIAAA model) [J].Nat Protoc, 2013, 8 (3) :627-637.
|
|
[14]KI SH, PARK O, ZHENG M, et al.Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding:role of signal transducer and activator of transcription 3[J].Hepatology, 2010, 52 (4) :1291-1300.
|
|
[15] BERTOLA A, PARK O, GAO B.Chronic plus binge ethanol feeding synergistically induces neutrophil infiltration and liver injury:A critical role for E-selectin[J].Hepatology, 2013, 58 (5) :1814-1823.
|
|
[16]LI H.The regulation of liver fibrosis by immune cells[J].J Clin Hepatol, 2012, 28 (1) :74-77. (in Chinese) 李海.免疫细胞对肝脏纤维化的调控作用[J].临床肝胆病杂志, 2012, 28 (1) :74-77.
|
|
[17]INOKUCHI S, TSUKAMOTO H, PARK E, et al.Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrowderived and endogenous liver cells in mice[J].Alcohol Clin Exp Res, 2011, 35 (8) :1509-1518.
|
|
[18]JEONG WI, PARK O, GAO B.Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis[J].Gastroenterology, 2008, 134 (1) :248-258.
|
|
[19]McKILLOP IH, SCHRUM LW.Role of alcohol in liver carcinogenesis[J].Semin Liver Dis, 2009, 29 (2) :222-232.
|
|
[20]ESFANDIARI F, MEDICI V, WONG DH, et al.Epigenetic regulation of hepatic endoplasmic reticulum stress pathways in the ethanolfed cystathionine beta synthase-deficient mouse[J].Hepatology, 2010, 51 (3) :932-941.
|
|
[21]DOLGANIUC A, PETRASEK J, KODYS K, et al.MicroRNA expression profile in Lieber-DeCarli diet-induced alcoholic and methionine choline deficient diet-induced nonalcoholic steatohepatitis models in mice[J].Alcohol Clin Exp Res, 2009, 33 (10) :1704-1710.
|
|
[22]JUNG Y, BROWN KD, WITEK RP, et al.Accumulation of hedgehogresponsive progenitors parallels alcoholic liver disease severity in mice and humans[J].Gastroenterology, 2008, 134 (5) :1532-1543.
|
|
[23]DALAKAS E, NEWSOME PN, BOYLE S, et al.Bone marrow stem cells contribute to alcohol liver fibrosis in humans[J].Stem Cells Dev, 2010, 19 (9) :1417-1425.
|
|
[24]SOYKA M, ROSNER S.Emerging drugs to treat alcoholism[J].Expert Opin Emerg Drugs, 2010, 15 (4) :695-711.
|
|
[25]ADDOLORATO G, LEGGIO L.Safety and efficacy of baclofen in the treatment of alcohol-dependent patients[J].Curr Pharm Des, 2010, 16 (19) :2113-2117.
|
|
[26]MATHURIN P, O’GRADY J, CARITHERS RL, et al.Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis:meta-analysis of individual patient data[J].Gut, 2011, 60 (2) :255-260.
|
|
[27]RAMBALDI A, SACONATO HH, CHRISTENSEN E, et al.Systematic review:glucocorticosteroids for alcoholic hepatitis—a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials[J].Aliment Pharmacol Ther, 2008, 27 (12) :1167-1178.
|
|
[28]KENDRICK SF, HENDERSON E, PALMER J, et al.Theophylline improves steroid sensitivity in acute alcoholic hepatitis[J].Hepatology, 2010, 52 (1) :126-131.
|
|
[29] di MAMBRO AJ, PARKER R, McCUNE A, et al.In vitro steroid resistance correlates with outcome in severe alcoholic hepatitis[J].Hepatology, 2011, 53 (4) :1316-1322.
|
|
[30]de BK, GANGOPADHYAY S, DUTTA D, et al.Pentoxifylline versus prednisolone for severe alcoholic hepatitis:a randomized controlled trial[J].World J Gastroenterol, 2009, 15 (13) :1613-1619.
|
|
[31]WHITFIELD K, RAMBALDI A, WETTERSLEV J, et al.Pentoxifylline for alcoholic hepatitis[J].Cochrane Database Syst Rev, 2009, 4:CD007339.
|
|
[32]BOETTICHER NC, PEINE CJ, KWO P, et al.A randomized, doubleblinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis[J].Gastroenterology, 2008, 135 (6) :1953-1960.
|
|
[33]MATO JM, CAMARA J, FERNANDEZ de PAZ J, et al.S-adenosylmethionine in alcoholic liver cirrhosis:a randomized, placebo-controlled, double-blind, multicenter clinical trial[J].J Hepatol, 1999, 30 (6) :1081-1089.
|
|
[34]RAMBALDI A, GLUUD C.S-adenosyl-L-methionine for alcoholic liver diseases[J].Cochrane Database Syst Rev, 2006, 2:CD002235.
|
|
[35]FEDE G, GERMANI G, GLUUD C, et al.Propylthiouracil for alcoholic liver disease[J].Cochrane Database Syst Rev, 2011, 6:CD002800.
|
|
[36] KONG F, FENG D, GAO B.Hepatoprotective and anti-fibrotic functions of IL-22:therapeutic potential for the treatment of alcoholic liver disease[J].J Gastro Hepatol, 2013, 28 (Suppl 1) :56-60.
|
|
[37]BASS NM, MULLEN KD, SANYAL A, et al.Rifaximin treatment in hepatic encephalopathy[J].N Engl J Med, 2010, 362 (12) :1071-1081.
|
|
[38]SHIFFMAN ML, POCKROS P, McHUTCHISON JG, et al.Clinical trial:the efficacy and safety of oral PF-03491390, a pancaspase inhibitor—a randomized placebo-controlled study in patients with chronic hepatitis C[J].Aliment Pharmacol Ther, 2010, 31 (9) :969-978.
|
|
[39]SETH D, GORRELL MD, CORDOBA S, et al.Intrahepatic gene expression in human alcoholic hepatitis[J].J Hepatol, 2006, 45 (2) :306-320.
|
|
[40]TAM J, LIU J, MUKHOPADHYAY B, et al.Endocannabinoids in liver disease[J].Hepatology, 2011, 53 (1) :346-355.
|
|
[41]MOOKERJEE RP, WIESENTHAL A, ICKING A, et al.Increased gene and protein expression of the novel eNOS regulatory protein NOSTRIN and a variant in alcoholic hepatitis[J].Gastroenterology, 2007, 132 (7) :2533-2541.
|
DownLoad: